Certified by Founder
Lodge
Callio Therapeutics
start up

- 06/03/2025
- Series A
- $187,000,000
Realizing the promise of multi-payload antibody-drug conjugates to improve cancer therapy
- Industry Biotechnology Research
- Website https://calliotx.com/
- LinkedIn https://www.linkedin.com/company/calliotx/